Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) Other Non Operating Income (2021 - 2025)

Journey Medical's Other Non Operating Income history spans 5 years, with the latest figure at -$19000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income changed N/A year-over-year to -$19000.0, compared with a TTM value of -$90000.0 through Dec 2025, down 108.4%, and an annual FY2025 reading of -$90000.0, down 108.0% over the prior year.
  • Other Non Operating Income for Q4 2025 was -$19000.0 at Journey Medical, down from -$3000.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $1.1 million in Q3 2024, with the low at -$263000.0 in Q4 2021.
  • Average Other Non Operating Income over 5 years is $16437.5, with a median of -$27000.0 recorded in 2022.
  • Year-over-year, Other Non Operating Income plummeted 1000.0% in 2022 and then skyrocketed 1213.86% in 2024.
  • Tracing DERM's Other Non Operating Income over 5 years: stood at -$263000.0 in 2021, then skyrocketed by 74.52% to -$67000.0 in 2022, then surged by 97.01% to -$2000.0 in 2023, then soared by 56350.0% to $1.1 million in 2024, then plummeted by 101.69% to -$19000.0 in 2025.
  • Per Business Quant, the three most recent readings for DERM's Other Non Operating Income are -$19000.0 (Q4 2025), -$3000.0 (Q3 2025), and -$61000.0 (Q2 2025).